Literature DB >> 24261813

Characterization of fungal keratitis in alpacas: 11 cases (2003-2012).

Eric C Ledbetter1, Keith W Montgomery, Matthew P Landry, Nathan C Kice.   

Abstract

OBJECTIVE: To describe clinical, microbiological, in vivo confocal microscopic, and histopathologic features of fungal keratitis in alpacas and to estimate prevalence of the disease in a population of alpacas from the northeastern United States.
DESIGN: Retrospective case series. Animals-11 alpacas. PROCEDURES: Medical records of alpacas evaluated by the ophthalmology service of a veterinary teaching hospital were searched to identify animals with a clinical diagnosis of fungal keratitis and positive results for fungal culture of a corneal sample between 2003 and 2012. Signalment and historical, clinical, and microbiological details were recorded. Results of cytologic, histopathologic, and in vivo confocal microscopic corneal examinations were collected when available.
RESULTS: Fungal keratitis was diagnosed in 11 of 169 (6.5%) alpacas that underwent ophthalmologic examination by the ophthalmology service during the study period. Ten of the 11 alpacas were evaluated in the summer or fall months. Corneal lesions included stromal ulcer, stromal abscess, corneal perforation, and nonulcerative keratitis. Aspergillus fumigatus and Fusarium solani were the most frequently cultured fungi. Fungi were also identified through corneal cytologic examination, histologic examination, or in vivo confocal microscopy in 9 alpacas. Historically, 2 alpacas were evaluated following external ocular trauma and 1 following corneal foreign body removal. Nine alpacas had received topical treatment with antimicrobials and 2 had antimicrobial-corticosteroid combinations administered topically prior to referral. Nine of 10 alpacas for which follow-up information was available were successfully treated, with globe and vision retention. CONCLUSIONS AND CLINICAL RELEVANCE: Fungal keratitis was a relatively common ocular disease in this population of alpacas and appeared to share several clinical features with keratomycosis in horses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24261813     DOI: 10.2460/javma.243.11.1616

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  7 in total

1.  In vivo ocular imaging of the cornea of the normal female laboratory beagle using confocal microscopy.

Authors:  Ann R Strom; Dennis E Cortés; Sara M Thomasy; Philip H Kass; Mark J Mannis; Christopher J Murphy
Journal:  Vet Ophthalmol       Date:  2015-03-06       Impact factor: 1.644

2.  Diagnostic Ophthalmology.

Authors:  Stephanie Osinchuk; Bruce Grahn
Journal:  Can Vet J       Date:  2018-03       Impact factor: 1.008

3.  IL-17 produced by Th17 cells alleviates the severity of fungal keratitis by suppressing CX43 expression in corneal peripheral vascular endothelial cells.

Authors:  Xiu-Hong Qin; Xiang Ma; Shi-Feng Fang; Zhen-Zhen Zhang; Jian-Min Lu
Journal:  Cell Cycle       Date:  2019-01-20       Impact factor: 4.534

4.  Keratomycosis in captive red pandas (Ailurus fulgens): 2 cases.

Authors:  Hayley August Volk; Anu O'Reilly; Kate Bodley; Helen McCracken
Journal:  Open Vet J       Date:  2018-06-01

5.  The effect of environmental and biological factors on STT I and normal total tear protein concentration in Japanese black calves.

Authors:  Yukino Suyama; Keiichi Matsuda; Takahiro Teshima; Hirotaka Matsumoto; Hidekazu Koyama
Journal:  J Vet Med Sci       Date:  2018-11-16       Impact factor: 1.267

6.  Ophthalmology of clinically normal alpacas (Vicugna pacos) in the United Kingdom: a cross-sectional study.

Authors:  Josephine Faulkner; David Leonard Williams; Karin Mueller
Journal:  Vet Rec       Date:  2020-04-17       Impact factor: 2.695

7.  Case Report: Successful Management of Refractory Keratomycosis in an Alpaca Using Penetrating Keratoplasty and Combination Antifungal Therapy (Caspofungin 0.5% and Terbinafine 1%).

Authors:  Braidee C Foote; Joe S Smith; Anna Catherine Bowden; Rachel A Allbaugh; Lionel Sebbag
Journal:  Front Vet Sci       Date:  2021-03-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.